The Medicines Management Team champions primary care transformation
Founded in 2017 by Advanced Clinical Practitioners Fahad Qureshi and Mohammed Rashad, The Medicines Management Team is an award-winning UK provider of clinical services, recruitment, and training solutions tailored for GP surgeries and Primary Care Networks (PCNs). Based in Bradford, the company is a key player in enhancing pharmacist-led care by partnering with local apprenticeship programmes to support the transition of pharmacists and pharmacy technicians into primary care roles. By focusing on upskilling and benchmarking, the business plays a crucial role in bolstering the NHS workforce and ensuring the delivery of safe, effective primary care services.
Strategic vision and mission
With a mission to reduce the workload of healthcare professionals, The Medicines Management Team leverages artificial intelligence (AI) and its clinical expertise to streamline healthcare processes. This enhances both the efficiency and accessibility of care, supporting the NHS’s goals to improve service delivery and resilience. The company’s vision is to lead in primary care by harnessing advanced training and technology, aiming to cultivate a network of skilled pharmacists and technicians prepared to implement the NHS long-term plan.
Expansive growth plans
Over the next three years, The Medicines Management Team is set to expand its reach nationwide, aiming to partner with more GP surgeries and PCNs to deliver pharmacist-led services in primary care. The company plans to enhance its training and development programmes, supporting the professional growth of pharmacy professionals into advanced primary care roles. Moreover, it intends to integrate more innovative technologies to optimise patient care and strengthen local apprenticeship programmes, aligning with NHS objectives to forge a more efficient and accessible healthcare system.
“It has been great working with Fahad and Rashad at The Medicines Management Team, from initially discussing their growth plans and any support they required to reach those plans to supporting them in refining and choosing the most effective coach for their plans.”
Jas Hayre, Client Manager – The West Yorkshire Good Growth Programme
Overcoming unique challenges
As Asian business leaders, the founders of The Medicines Management Team navigate unique challenges, including cultural biases and the need to establish credibility in a sector where they may be underrepresented. Despite these obstacles, they have cultivated resilience and innovative thinking, which have become invaluable assets in their successful business operations.
Encouraging diverse leadership in healthcare
The Medicines Management Team champions the benefits of initiatives like the West Yorkshire Good Growth Programme, highlighting the invaluable support, resources, and opportunities they offer for business growth and stability. The company is keen to encourage more Asian-led businesses to embrace these programmes, emphasising the tangible advantages such as mentorship and networking opportunities that significantly aid in business expansion. Through sharing success stories and promoting community engagement, the business aims to alleviate hesitations among minority business leaders and inspire them to access these vital resources.
“The Good Growth Programme has been incredibly supportive, helping us access valuable resources and connections to further expand our business. We’ve especially benefited from their guidance in scaling our services and enhancing our operational strategies, which has allowed us to broaden our impact in primary care. The programme’s networking opportunities and mentorship have been instrumental, enabling us to refine our growth plans and strengthen our local and national partnerships effectively.”
Mohammed Rashad, Advanced Clinical Practitioner – The Medicines Management Team
Continued contribution to healthcare excellence
In recent discussions, The Medicines Management Team has highlighted its ongoing commitment to reducing health inequalities and enhancing patient care, actively contributing to the NHS long term plan. These efforts underscore the company’s role as a pivotal player in the future of healthcare delivery in the UK.